In a report released on January 9, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Cogstate Ltd (COGZF – Research Report), with a price target of A$2.50. The company’s shares closed last Tuesday at $1.32.
According to TipRanks, Shapiro is ranked #5438 out of 8183 analysts.
Currently, the analyst consensus on Cogstate Ltd is a Moderate Buy with an average price target of $1.57.
See Insiders’ Hot Stocks on TipRanks >>
COGZF market cap is currently $229.2M and has a P/E ratio of 30.41.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cogstate Ltd is a cognitive science company. The principal activity of the company is a sale of technology and services for the measurement of cognition, where services include scientific consultancy, project management, data management, statistical analysis and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In clinical trials segment, technology and services are sold to pharmaceutical, biotechnology, nutraceutical, and functional food companies.
